Skip to main content
Hit enter to search or ESC to close
Close Search
RIS RxRIS Rx
Menu
  • Our Platform
  • Insights
  • Our Story
  • Get My GTN Assessment

    Gerard Rivera

    Co-founder & CEO
    Gerard Rivera

    Gerard Rivera

    Co-founder & CEO

    Gerard serves as CEO of RIS Rx, which he co-founded in 2020. In partnership with the RIS Rx executive team, Gerard is pioneering gross-to-net (GTN) revenue protection with direct impact to millions of patients and the pharmaceutical manufacturers that support them. His background spans frontline pharmacy, patient access & affordability operations, with leadership experience across multiple pharmacy services and healthcare organizations. He earned his PharmD from Loma Linda University.

    Insights
    From Leakage to Leverage: How RIS Rx Is Redefining Patient Affordability at Scale
    From Leakage to Leverage: How RIS Rx Is Redefining Patient Affordability at Scale

    February 17, 2026

    Gerard Rivera
    Gerard Rivera Co-founder & CEO
    GTN Insights
    Welcoming Leslie Donato to our Board of Directors
    Welcoming Leslie Donato to our Board of Directors

    December 22, 2025

    Gerard Rivera
    Gerard Rivera Co-founder & CEO
    Our PeoplePress Releases
    Welcoming Stuart McGuigan to our Board of Directors
    Welcoming Stuart McGuigan to our Board of Directors

    December 17, 2025

    Gerard Rivera
    Gerard Rivera Co-founder & CEO
    Our PeoplePress Releases
    Grateful for the People Behind the Progress
    Grateful for the People Behind the Progress

    November 25, 2025

    Gerard Rivera
    Gerard Rivera Co-founder & CEO
    Our People
    GTN Leakage Is Overwhelming Pharma Leaders—and It Shouldn’t Be
    GTN Leakage Is Overwhelming Pharma Leaders—and It Shouldn’t Be

    November 18, 2025

    Gerard Rivera
    Gerard Rivera Co-founder & CEO
    PBM / Payer-based Leakage
    Affordability Programs Aren’t Optional. They’re Life-Saving.
    Affordability Programs Aren’t Optional. They’re Life-Saving.

    October 30, 2025

    Gerard Rivera
    Gerard Rivera Co-founder & CEO
    PBM / Payer-based Leakage
    From Copay Blind Spots to $1B Saved: Why We Built RIS Rx
    From Copay Blind Spots to $1B Saved: Why We Built RIS Rx

    October 24, 2025

    Gerard Rivera
    Gerard Rivera Co-founder & CEO
    Our Story
    Welcoming John Driscoll as Chairman of our Board of Directors
    Welcoming John Driscoll as Chairman of our Board of Directors

    October 15, 2025

    Gerard Rivera
    Gerard Rivera Co-founder & CEO
    Our PeoplePress Releases
    The $90B Problem No One Sees at the Pharmacy Counter
    The $90B Problem No One Sees at the Pharmacy Counter

    September 15, 2025

    Gerard Rivera
    Gerard Rivera Co-founder & CEO
    PBM / Payer-based Leakage

    Learn why the world's top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.

    "*" indicates required fields

    Consent*
    GTN areas I‘d like to explore:
    • Our Platform
    • Insights
    • Our Story
    • Contact
    • Careers
    • Press
    Get My GTN Assessment

    RIS Rx offers real-time GTN Revenue Protection to the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patient at the right time.

    • Sitemap
    • Terms of Use
    • Privacy Policy
    • Cookie Settings
    • Do Not Sell My Personal Information
    Close Menu
    • Our Platform
    • Insights
    • Our Story
    • Get Assessment

    RIS Rx is pioneering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patients at the right time.